Aclarion Inc.
Organization details
- Legal name
- Aclarion Inc.
- Former names
- Nocimed, Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 8071 — Services-Medical Laboratories
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Broomfield
- Headquarters state / province
- Colorado
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- ACON
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001635077
- EIN
- 47-3324725
Board of directors
-
Amanda Mae Sequira · DirectorSince 2026
-
Brent Ness · Director · Chief Executive OfficerSince 2025
-
David K. Neal · DirectorSince 2026
-
Jeffrey John Thramann · Director · Executive ChairmanSince 2023
-
Ryan Bond · DirectorSince 2026
-
Scott Breidbart · DirectorSince 2026
-
Stephen Deitsch · DirectorSince 2026
-
William Wesemann · DirectorSince 2026
Chief executives
Director election results
Annual meeting of June 4, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
60.2%
-
67.5%
-
67.9%
-
68.0%
-
68.4%
-
68.4%
Board connections
2 of this board's directors also sit on 1 other board.
- via Jeffrey John Thramann and Stephen Deitsch
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $176,647
- 11 purchases by 7 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 17, 2026 | Amanda Mae Sequira Director | Open-market purchase | +5,857 | $2.73 | $15,990 |
| Aug 14, 2026 | Gould Gregory A Officer (CFO) | Open-market purchase | +10,000 | $2.45 | $24,500 |
| Aug 13, 2026 | Brent Ness Director, Officer (Chief Executive Officer) | Open-market purchase | +5,234 | $2.31 | $12,091 |
| Aug 13, 2026 | David K. Neal Director | Open-market purchase | +7,500 | $2.40 | $18,000 |
| Aug 13, 2026 | William Wesemann Director | Open-market purchase | +2,150 | $2.34 | $5,031 |
| Aug 13, 2026 | Ryan Bond Director | Open-market purchase | +21,122 | $2.37 | $50,059 |
| Jun 11, 2026 | Bond Ryan Officer (Chief Strategy Officer) | Grant or award | +55,000 | — | — |
| Jun 11, 2026 | Amanda Mae Sequira Director | Grant or award | +20,000 | — | — |
| Jun 11, 2026 | Gould Gregory A Officer (Chief Financial Officer) | Grant or award | +50,000 | — | — |
| Jun 11, 2026 | Scott Breidbart Director | Grant or award | +20,000 | — | — |
| Jun 11, 2026 | Brent Ness Director, Officer (Chief Executive Officer) | Grant or award | +100,000 | — | — |
| Jun 11, 2026 | William Wesemann Director | Grant or award | +20,000 | — | — |
| Jun 11, 2026 | David K. Neal Director | Grant or award | +20,000 | — | — |
| Jun 11, 2026 | Jeffrey John Thramann Director, Officer (Executive Chairman) | Grant or award | +100,000 | — | — |
| Jun 11, 2026 | Stephen Deitsch Director | Grant or award | +20,000 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Aclarion Inc.
Who is the CEO of Aclarion Inc.?
Brent Ness is Aclarion Inc.'s Chief Executive Officer.
How many directors are on Aclarion Inc.'s board?
Aclarion Inc.'s board has 8 directors: Amanda Mae Sequira, Brent Ness, David K. Neal, Jeffrey John Thramann, Ryan Bond, Scott Breidbart, Stephen Deitsch and William Wesemann.
Are Aclarion Inc. insiders buying or selling shares?
Over the last 12 months, Aclarion Inc. insiders bought $176,647 of shares in 11 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="aclarion-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.